CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 4 Other acquisition Director acquired 67,678 shares (other)
- 4 Grant or award Chief Financial Officer acquired 1,270,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4/A Open-market sale Chief Executive Officer sold 18,948 shares at $0.71 ($13,453)
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes Chief Executive Officer gave up 18,948 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Shares withheld for taxes Chief Medical Officer gave up 13,038 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 4 Shares withheld for taxes Chief Executive Officer gave up 19,110 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 21 of 26 · 506 filings